Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial.
Haizhen Yang(Peking University), Xuejun Zhu, Baoxi Wang(Air Force Medical University), Hongzhong Jin(Wuhan University), Su-Zhen Ji, Furen Zhang(Shandong Provincial Institute of Dermatology and Venereology), Yang Shen(Shanghai Institute of Hematology), Ke Wang(Zhejiang Chinese Medical University), Chunyang Li(Shandong University), Jinhua Xu(Fudan University), Tianwen Gao(Xijing Hospital), Shengxiang Xiao(Second Affiliated Hospital of Xi'an Jiaotong University), Cai‐Xia Tu(Dalian Medical University), Xiaoming Liu(Huazhong University of Science and Technology)
PubMed
June 1, 2012
Cited by 73
Related Papers
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
|Nature Genetics|2011|818
Association analyses identify six new psoriasis susceptibility loci in the Chinese population
|Nature Genetics|2010|317
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
|Journal of Experimental & Clinical Cancer Research|2018|176
Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression
|OncoImmunology|2022|163
Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis
|Chinese Medical Journal|2016|110